Would it be recommended treating multiple sclerosis relapses with high dose oral instead intravenous steroids during the COVID-19 pandemic? Yes.

Publication date: Available online 20 August 2020Source: Multiple Sclerosis and Related DisordersAuthor(s): Constanza Segamarchi, Berenice Silva, Patricia Saidon, Orlando Garcea, Ricardo Alonso
Source: Multiple Sclerosis and Related Disorders - Category: Neurology Source Type: research

Related Links:

Publication date: Available online 8 October 2020Source: Neurología (English Edition)Author(s): V.M. Rivera, F. Gracia, A. Díaz
Source: Neurologia - Category: Neurology Source Type: research
Conclusions: The results provide a basis for the development of psychological interventions that could minimize the prevalence of sleep disorders and depression and could improve patients ’ quality of life during the outbreak.RESUMO Introdu ção: Este estudo relatou uma variedade de reações psicológicas relacionadas a ansiedade, qualidade do sono, depressão, fadiga e qualidade de vida em indivíduos com esclerose múltipla (EM), relacionadas à experiência de quarentena de COVID-19. Objetivo: O objetivo deste estudo foi invest igar os efeitos neuropsiqu...
Source: Arquivos de Neuro-Psiquiatria - Category: Neurology Source Type: research
Abstract The coronavirus disease 2019 (COVID-19), a serious respiratory illness caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has emerged as a global pandemic. Canada reported its first case of COVID-19 on 25th January 2020. By March 2020 the virus had spread within Canadian communities reaching the most frail and vulnerable elderly population in long-term care facilities. The majority of cases were reported in the provinces of Quebec, Ontario, Alberta and British Columbia and the highest mortality was seen among individuals aged 65 years or older. Canada has the highest prevalence an...
Source: Biochemistry and Cell Biology - Category: Biochemistry Authors: Tags: Biochem Cell Biol Source Type: research
Publication date: Available online 3 October 2020Source: Multiple Sclerosis and Related DisordersAuthor(s): Aurora Zanghì, Emanuele D'Amico, Maria Luca, Marco Ciaorella, Lucia Basile, Francesco Patti
Source: Multiple Sclerosis and Related Disorders - Category: Neurology Source Type: research
Publication date: November 2020Source: Multiple Sclerosis and Related Disorders, Volume 46Author(s): Andre C. Vogel, Hollie Schmidt, Sara Loud, Robert McBurney, Farrah J. Mateen
Source: Multiple Sclerosis and Related Disorders - Category: Neurology Source Type: research
Publication date: November 2020Source: Multiple Sclerosis and Related Disorders, Volume 46Author(s): Nabil Seery, Vivien Li, Ai-Lan Nguyen, Izanne Roos, Katherine A Buzzard, Roberts Atvars, Nicola Taylor, Kelsey Tunnell, John Carey, Chris Dwyer, Hasini Fernandoa Lisa Taylor, Josephine Baker, Mark P Marriott, Trevor J Kilpatrick, Tomas Kalincik, Mastura Monif
Source: Multiple Sclerosis and Related Disorders - Category: Neurology Source Type: research
With nearly 200,000 Americans dead from COVID-19 and millions more who lost their health insurance when they lost their jobs this year, President Donald Trump tried this week—as he has done throughout his presidency—to change the conversation. On Sunday, the President issued a new executive order aimed at lowering prescription drug prices, an issue dear to many voters, and boasted on Twitter that “prices are coming down FAST.” The reality is more complicated. Trump’s new executive order, which revokes and replaces a different executive order on drug prices that he signed in July, directs the...
Source: TIME: Health - Category: Consumer Health News Authors: Tags: Uncategorized 2020 Election COVID-19 Explainer News Source Type: news
The current COVID-19 pandemic presents unprecedented new challenges to public health and medical care delivery. To control viral transmission, social distancing measures have been implemented all over the world, interrupting the access to routine medical care for many individuals with neurological diseases. Cognitive disorders are common in many neurological conditions, e.g., stroke, traumatic brain injury, Alzheimer's disease, and other types of dementia, Parkinson's disease and parkinsonian syndromes, and multiple sclerosis, and should be addressed by cognitive rehabilitation interventions. To be effective, cognitive reh...
Source: Frontiers in Neurology - Category: Neurology Source Type: research
Before we get on with this week’s Psychology Around the Net, I need to let you know that this will be the last one. Healthline has purchased Psych Central and content production stops August 31, 2020. Dr. John Grohol, Psych Central’s founder and our fearless leader, recently shared his reflections and gratitude. Additionally, many of our talented and knowledgeable contributers have shared goodbye posts, and invitations to follow their new blogs. Now, let’s see what’s new in the world of mental health this week! The Psychology Behind Why Some College Students Break COVID-19 Rules: According to deve...
Source: World of Psychology - Category: Psychiatry & Psychology Authors: Tags: Psychology Around the Net Burnout College Students coronavirus COVID-19 Fatigue Happiness Life Satisfaction Mood pandemic Source Type: blogs
Why focus on multiple sclerosis (MS) and wellness during the coronavirus disease 2019 (COVID-19) pandemic? People with MS have considerable experience coping with the uncertainty that goes along with having a highly variable, progressive disease. The COVID-19 pandemic presents new uncertainties that likely challenge the coping resources of persons with MS and cause disruptions in lifestyle habits and choices that affect wellness. Anxiety, depression, loneliness, and sedentary behavior are common in MS and now may be exacerbated by the physical distancing necessitated by the pandemic.
Source: Archives of Physical Medicine and Rehabilitation - Category: Rehabilitation Authors: Tags: Editorial Source Type: research
More News: COVID-19 | Multiple Sclerosis | Neurology | Pandemics